Sign Out
Mirapex ER extended-release tablet 0.375 mg: The tablets are white to off-white, round, biconvex, bevel-edged tablets, one side debossed with the
Boehringer Ingelheim company symbol and the other side debossed with P1.
Mirapex ER extended-release tablet 0.75 mg: The tablets are white to off-white, round, biconvex, bevel-edged tablets, one side debossed with the
Boehringer Ingelheim company symbol and the other side debossed with P2.
Mirapex ER extended-release tablet 1.5 mg: The tablets are white to off-white, oval, biconvex tablets, one side debossed with the Boehringer Ingelheim
company symbol and the other side debossed with P3.
Each extended-release tablet contains 0.375 mg, 0.75 mg or 1.5 mg pramipexole dihydrochloride monohydrate respectively equivalent to 0.26 mg, 0.52 mg or 1.05 mg pramipexole.
Note: Pramipexole doses as published in the literature refer to the salt form.
Therefore, doses will be expressed in terms of pramipexole salt.
Excipients/Inactive Ingredients: Hypromellose 2208, Maize starch, Carbomer 941, Colloidal anhydrous silica, Magnesium stearate.
Continue with Google